Antitumor Effect of Luteolin Proven by Patient-Derived Organoids of Gastric Cancer

Researchers elucidated the antitumor activity of luteolin in gastric cancer (GC) patient-derived organoids (PDOs). PDOs were established from GC cancer tissues, and the characterization of tissues and PDOs was performed using whole-exome sequencing.